首页> 外国专利> POLYNUCLEOTIDE COMPRISING A NON - NATURALLY OCCURRING HCV SEQUENCE THAT IS CAPABLE OF PRODUCTIVE REPLICATION IN A HOST CELL, VECTORS, CELLS AND A METHOD FOR IDENTIFYING CELL LINE PERMISSIVE FOR INFECTION WITH HCV

POLYNUCLEOTIDE COMPRISING A NON - NATURALLY OCCURRING HCV SEQUENCE THAT IS CAPABLE OF PRODUCTIVE REPLICATION IN A HOST CELL, VECTORS, CELLS AND A METHOD FOR IDENTIFYING CELL LINE PERMISSIVE FOR INFECTION WITH HCV

机译:包含非自然产生的HCV序列的多核苷酸,可在宿主细胞,载体,细胞中进行生产性复制,以及一种鉴定允许感染HCV的细胞系的方法

摘要

HCV variants are described. The variants include polynucleotides comprising non-naturally occurring HCV sequences and HCV variants that have a transfection efficiency and ability to survive subpassage greater than HCV that have wild-type polyprotein coding regions. Expression vectors comprising the above polynucleotides and HCV variants are also described, as are the provision of cells and host cells comprising the expression vectors. Methods for identifying a cell line that is permissive for infection with HCV are also provided, as are vaccines comprising the above polynucleotides in a pharmaceutically acceptable carrier. Additionally, methods for inducing immunoprotection to HCV in a primate are described, as are methods for testing a compound for inhibiting HCV replication.
机译:描述了HCV变体。变体包括包含非天然存在的HCV序列和具有野生型多蛋白编码区的HCV变体的多核苷酸,所述HCV变体具有比HCV更大的转染效率和存活能力,且具有高于野生型多蛋白编码区的HCV。还描述了包含上述多核苷酸和HCV变体的表达载体,以及包含表达载体的细胞和宿主细胞的提供。还提供了鉴定允许HCV感染的细胞系的方法,以及在药学上可接受的载体中包含上述多核苷酸的疫苗。另外,描述了在灵长类动物中诱导对HCV的免疫保护的方法,以及测试用于抑制HCV复制的化合物的方法。

著录项

  • 公开/公告号IL152671A

    专利类型

  • 公开/公告日2009-09-01

    原文格式PDF

  • 申请/专利权人 WASHINGTON UNIVERSITY;

    申请/专利号IL20020152671

  • 发明设计人

    申请日2002-11-06

  • 分类号C12N15/09;A61K31/7088;A61K39;A61K39/29;A61K48;A61P1/16;A61P31/14;C07K14/18;C12N5/10;C12N5/22;C12N15/85;C12Q1/02;

  • 国家 IL

  • 入库时间 2022-08-21 19:27:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号